U-118 MG人脑星形胶质母细胞瘤
文献支持

U-118 MG人脑星形胶质母细胞瘤

收藏
  • ¥1350
  • 中乔新舟已认证
  • 中国
  • ZQ0411
  • 2025年12月04日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 英文名

      U-118 MG

    • 库存

      大量

    • 供应商

      中乔新舟

    • 细胞类型

      细胞系

    • 品系

      human

    • 组织来源

      human

    • 相关疾病

    • 物种来源

      human

    • 免疫类型

    • 细胞形态

      咨询销售

    • 器官来源

      human

    • 运输方式

      T25瓶运输

    • 年限

      5-10年

    • 生长状态

      贴壁生长

    • 规格

      5 x 10^5 cells/vial

    产品名称

    U-118 MG人脑星形胶质母细胞瘤

    货号

    ZQ0411

    产品介绍

    U-118 MG 是一种表现出混合形态的细胞系,于 1966 年从一名患有 IV 级胶质母细胞瘤的 50 岁男性的恶性胶质瘤中分离出来。

    注意: 据报道来自不同个体的胶质母细胞瘤细胞株U-118 MG (HTB-15) 和 U-138 MG (HTB-16)有着一致的VNTR和相近的STR模式。 U-118 MG 和 U-138 MG细胞遗传学上很相似并有至少六个衍生标记染色体。 这是1966年至1969年间J. Ponten和同事从恶性神经胶质瘤中构建的细胞株中的一株(其它包括ATCC HTB-14和 ATCC HTB-16 and ATCC HTB-17)。 1987年用BM-Cycline培养6周去除了支原体污染。

    注意事项:
    U-118 MG细胞对温度比较敏感,易收缩。

    种属

    性别/年龄

    男/50岁

    组织

    疾病

    胶质母细胞瘤;四级

    细胞类型

    肿瘤细胞 

    形态学

    混合的

    生长方式

    贴壁

    倍增时间

    大约48~72小时 

    培养基和添加剂

    DMEM高糖(品牌:中乔新舟  货号:ZQ-100)+10%FBS(品牌:中乔新舟  货号:ZQ500-A)+1%P/S(中乔新舟  货号:CSP006)

    推荐完全培养基货号

    ZM0411

    生物安全等级

    BSL-1

    STR位点信息

    Amelogenin: X,Y

    CSF1PO: 11,12

    D13S317: 9

    D16S539: 12,13

    D5S818: 11

    D7S820: 9

    TH01: 6

    TPOX: 8

    vWA: 18

    培养条件

    95%空气,5%二氧化碳;37℃

    抗原表达/受体表达

     ***

    基因表达

     ***

    保藏机构

    ATCC; HTB-15

    供应限制

    仅供科研使用

    上海中乔新舟生物科技有限公司成立于2011年,历经十多年发展,主要专注于细胞生物学产品的研究和开发,专注于为药企、各类科研机构及CRO企业提供符合标准规范的细胞培养服务、细胞培养基、细胞检测试剂盒、细胞培养试剂,胎牛血清和细胞生物学技术服务等。

    公司一直致力于为高等院校、研究机构、医院、CRO及CDMO企业提供细胞培养完整解决方案,这些产品旨在满足细胞培养的多样需求,确保实验和研究的有效进行。引用中乔新舟(ZQXZBIO)产品和服务的文献超数千篇。

    U-118 MG人脑星形胶质母细胞瘤

    产品服务

    细胞资源:原代细胞、细胞株、干细胞、示踪细胞、耐药株细胞、永生化细胞等基因工程细胞。

    试剂产品:胎牛血清、完全培养基(适用于原代细胞及细胞株)、无血清培养基、基础培养基、细胞转染试剂、重组因子、胰酶和双抗等等细胞培养所有实验相关产品。

    技术服务:稳转株构建、原代细胞分离、特殊培养基定制服务、细胞检测等。

    U-118 MG人脑星形胶质母细胞瘤

    目前产品已经畅销国内30多个省市,与客户建立长期的合作伙伴关系,共同实现成功。全体员工将不懈努力,继续为科研人员提供优良的产品和服务,致力成为全球细胞培养领域的参与者。

    U-118 MG人脑星形胶质母细胞瘤

    企业愿景

    致力于成为国内细胞培养基产业的佼佼者,生物医药领域上游原材料的优良提供商。

    企业使命

    成长为专业细胞系及原代细胞培养供应商、专业细胞培养基及培养试剂生产商。

    企业荣誉

    U-118 MG人脑星形胶质母细胞瘤

    U-118 MG人脑星形胶质母细胞瘤

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    论文标题: Acquired temozolomide resistance in MGMTlow gliomas is associated with regulation of homologous recombination repair by ROCK2
    DOI: 10.1038/s41419-022-04590-6
    发表时间: 2022-02-10
    期刊: Cell Death & Disease
    影响因子: 8.469
    货号: ZQ0411
    产品名称: U118 cells

     

     

    论文标题: Identification of Prognostic Biomarkers of Glioblastoma Based on Multidatabase Integration and Its Correlation with Immune-Infiltration Cells
    DOI: 10.1155/2022/3909030
    发表时间: 2022-05-31
    期刊: Journal of Oncology
    影响因子: 4.375
    货号: ZQ0411
    产品名称: U-118 MG cell
     

     

     

    PubMed=4313504; DOI=10.1111/j.1699-0463.1968.tb03502.x
    Ponten J., Macintyre E.H.
    Long term culture of normal and neoplastic human glia.
    Acta Pathol. Microbiol. Scand. 74:465-486(1968)

     

    PubMed=4312117; DOI=10.1242/jcs.5.3.583
    Macintyre E.H., Grimes R.A., Vatter A.E.
    Cytology and growth characteristics of human tumour astrocytes transformed by Rous sarcoma virus.
    J. Cell Sci. 5:583-602(1969)

     

    PubMed=4337530; DOI=10.1111/j.1699-0463.1972.tb02176.x
    Macintyre E.H., Ponten J., Vatter A.E.
    The ultrastructure of human and murine astrocytes and of human fibroblasts in culture.
    Acta Pathol. Microbiol. Scand. A. 80:267-283(1972)

     

    PubMed=4134536; DOI=10.1002/ijc.2910120215
    Westermark B.
    The deficient density-dependent growth control of human malignant glioma cells and virus-transformed glia-like cells in culture.
    Int. J. Cancer 12:438-451(1973)

     

    PubMed=4369403; DOI=10.1002/1097-0142(197408)34:2<274::AID-CNCR2820340209>3.0.CO;2-4
    Wahlstrom T., Linder E., Saksela E., Westermark B.
    Tumor-specific membrane antigens in established cell lines from gliomas.
    Cancer 34:274-279(1974)

     

    DOI=10.1007/978-1-4757-1647-4_7
    Ponten J.
    Neoplastic human glia cells in culture.
    (In) Human tumor cells in vitro; Fogh J. (eds.); pp.175-206; Springer; New York (1975)

     

    PubMed=327080; DOI=10.1093/jnci/59.1.221
    Fogh J., Fogh J.M., Orfeo T.
    One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.
    J. Natl. Cancer Inst. 59:221-226(1977)

     

    PubMed=833871; DOI=10.1093/jnci/58.2.209
    Fogh J., Wright W.C., Loveless J.D.
    Absence of HeLa cell contamination in 169 cell lines derived from human tumors.
    J. Natl. Cancer Inst. 58:209-214(1977)

     

    PubMed=450131; DOI=10.1038/279797a0
    Day R.S. III, Ziolkowski C.H.J.
    Human brain tumour cell strains with deficient host-cell reactivation of N-methyl-N'-nitro-N-nitrosoguanidine-damaged adenovirus 5.
    Nature 279:797-799(1979)

     

    PubMed=6260907; DOI=10.1097/00005072-198105000-00001
    Bigner D.D., Bigner S.H., Ponten J., Westermark B., Mahaley M.S. Jr., Ruoslahti E., Herschman H., Eng L.F., Wikstrand C.J.
    Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas.
    J. Neuropathol. Exp. Neurol. 40:201-229(1981)

     

    PubMed=7017212; DOI=10.1093/jnci/66.6.1003
    Pollack M.S., Heagney S.D., Livingston P.O., Fogh J.
    HLA-A, B, C and DR alloantigen expression on forty-six cultured human tumor cell lines.
    J. Natl. Cancer Inst. 66:1003-1012(1981)

     

    PubMed=7459858
    Rousset M., Zweibaum A., Fogh J.
    Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins.
    Cancer Res. 41:1165-1170(1981)

     

    PubMed=6220172
    Dracopoli N.C., Fogh J.
    Polymorphic enzyme analysis of cultured human tumor cell lines.
    J. Natl. Cancer Inst. 70:469-476(1983)

     

    PubMed=3518877; DOI=10.3109/07357908609038260
    Fogh J.
    Human tumor lines for cancer research.
    Cancer Invest. 4:157-184(1986)

     

    PubMed=3675803
    Bigner S.H., Bjerkvig R., Laerum O.D., Muhlbaier L.H., Bigner D.D.
    DNA content and chromosomes in permanent cultured cell lines derived from malignant human gliomas.
    Anal. Quant. Cytol. Histol. 9:435-444(1987)

     

    PubMed=2454731
    Nister M., Libermann T.A., Betsholtz C., Pettersson M., Claesson-Welsh L., Heldin C.-H., Schlessinger J., Westermark B.
    Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines.
    Cancer Res. 48:3910-3918(1988)

     

    PubMed=2253244
    Bigner S.H., Humphrey P.A., Wong A.J., Vogelstein B., Mark J., Friedman H.S., Bigner D.D.
    Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts.
    Cancer Res. 50:8017-8022(1990)

     

    DOI=10.1016/B978-0-12-333530-2.50005-8
    Nister M., Westermark B.
    Human glioma cell lines.
    (In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.17-42; Academic Press; New York (1994)

     

    PubMed=9220028; DOI=10.1016/S0303-7207(97)00080-4
    Sharif T.R., Luo W., Sharif M.
    Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway.
    Mol. Cell. Endocrinol. 130:119-130(1997)

     

    DOI=10.1007/0-306-46861-1_11
    Ali-Osman F.
    Brain tumors.
    (In) Human cell culture. Vol. 2. Cancer cell lines part 2; Masters J.R.W., Palsson B.O. (eds.); pp.167-184; Kluwer Academic Publishers; New York (1999)

     

    PubMed=10402232; DOI=10.3892/ijo.15.2.237
    Sharif T.R., Sharif M.
    Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples.
    Int. J. Oncol. 15:237-243(1999)

     

    PubMed=10416987; DOI=10.1111/j.1750-3639.1999.tb00536.x
    Ishii N., Maier D., Merlo A., Tada M., Sawamura Y., Diserens A.-C., Van Meir E.G.
    Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines.
    Brain Pathol. 9:469-479(1999)

     

    PubMed=10560660; DOI=10.1097/00005072-199911000-00007
    Schmidt E.E., Ichimura K., Goike H.M., Moshref A., Liu L., Collins V.P.
    Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.
    J. Neuropathol. Exp. Neurol. 58:1170-1183(1999)

     

    PubMed=11414198; DOI=10.1007/s004320000207
    Lahm H., Andre S., Hoeflich A., Fischer J.R., Sordat B., Kaltner H., Wolf E., Gabius H.-J.
    Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.
    J. Cancer Res. Clin. Oncol. 127:375-386(2001)

     

    PubMed=16697959; DOI=10.1016/j.ccr.2006.03.030
    Lee J., Kotliarova S., Kotliarov Y., Li A.-G., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., Park J.K., Fine H.A.
    Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.
    Cancer Cell 9:391-403(2006)

     

    PubMed=19365568; DOI=10.1371/journal.pone.0005209
    Bax D.A., Little S.E., Gaspar N., Perryman L., Marshall L., Viana-Pereira M., Jones T.A., Williams R.D., Grigoriadis A., Vassal G., Workman P., Sheer D., Reis R.M., Pearson A.D.J., Hargrave D., Jones C.
    Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development.
    PLoS ONE 4:E5209-E5209(2009)

     

    PubMed=19435942; DOI=10.1215/15228517-2009-025
    Ichimura K., Pearson D.M., Kocialkowski S., Backlund L.M., Chan R., Jones D.T.W., Collins V.P.
    IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.
    Neuro-oncol. 11:341-347(2009)

     

    PubMed=20143388; DOI=10.1002/ijc.25242
    Capes-Davis A., Theodosopoulos G., Atkin I., Drexler H.G., Kohara A., MacLeod R.A.F., Masters J.R.W., Nakamura Y., Reid Y.A., Reddel R.R., Freshney R.I.
    Check your cultures! A list of cross-contaminated or misidentified cell lines.
    Int. J. Cancer 127:1-8(2010)

     

    PubMed=20164919; DOI=10.1038/nature08768
    Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
    Signatures of mutation and selection in the cancer genome.
    Nature 463:893-898(2010)

     

    PubMed=22460905; DOI=10.1038/nature11003
    Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
    The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
    Nature 483:603-607(2012)

     

    PubMed=22570425; DOI=10.1093/neuonc/nos072
    Bady P., Diserens A.-C., Castella V., Kalt S., Heinimann K., Hamou M.-F., Delorenzi M., Hegi M.E.
    DNA fingerprinting of glioma cell lines and considerations on similarity measurements.
    Neuro-oncol. 14:701-711(2012)


     

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1480
    上海酶研生物科技有限公司
    2025年07月14日询价
    ¥1800
    上海沪震实业有限公司
    2025年07月15日询价
    文献支持
    U-118 MG人脑星形胶质母细胞瘤
    ¥1350